Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -83.90% vs 565.48% in Dec 2025
Standalone Net Profit
QoQ Growth in quarter ended Mar 2026 is -108.50% vs 755.46% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -97.46% vs 6,559.52% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -7.14% vs -3.45% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Shukra Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -83.90% vs 565.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -52.52% vs 21.97% in Mar 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Mar 2026 is -108.50% vs 755.46% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -132.10% vs 35.09% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -97.46% vs 6,559.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -90.57% vs 65.24% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -7.14% vs -3.45% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -3.70% vs 285.71% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






